Renowned professor of Bioengineering David Mooney (Harvard) visits TU/e
From April 20th until May 1st, prof. David Mooney will visit the Institute for Complex Molecular Systems (ICMS) at Eindhoven University of Technology (TU/e) as distinguished ICMS professor. During his stay he will present a number of lectures, and he will interact with researchers of the ICMS.
Prof. Dave Mooney is Robert P. Pinkas Family Professor of Bioengineering. He is one of the founding fathers and Core Faculty Member of the Wyss Institute for Biologically Inspired Engineering at Harvard University.
The basic question that drives prof. Dave Mooney's research is: how do mammalian cells receive information from the materials in their environment? By utilizing the tools of cell and molecular biology, he studies the mechanisms by which chemical or mechanical signals are sensed by cells and alter their proliferation and specialization to either promote tissue growth or destruction.
Mooney uses the results from these studies to design and synthesize new biomaterials that regulate the gene expression of interacting cells for a variety of tissue engineering and drug delivery projects. Current projects focus on therapeutic angiogenesis, regeneration of musculoskeletal tissues, and cancer therapies.
Prof. Dave Mooney has published close to 400 papers in prestigious international journals, including Nature, Science and PNAS.
Public lecture – April 23th
On April 23th (13:00-14:30. TU/e, Ceres 0.31), Prof. David Mooney will give a public lecture, titled “Translational Research at the Wyss: Building bridges to the clinic and commercialization.”
The Wyss Institute at Harvard University was founded with the dual goals of both supporting high risk, high reward research, and moving discoveries made in the academic lab to clinical trials and commercialization. To facilitate translation, we have built strong ties to Boston-based hospitals, created a team of former industrial engineers, scientists, and business develop specialists to work with academic labs, and mechanisms to evaluate, and then resource the most promising inventions. This is an experiment in progress, and experiences to date will be shared.